These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23651418)

  • 1. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
    Iwata H; Kitajima Y
    Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-independent blistering mechanisms in bullous pemphigoid.
    Iwata H; Ujiie H
    Exp Dermatol; 2017 Dec; 26(12):1235-1239. PubMed ID: 28418613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
    Nishie W
    J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new in bullous pemphigoid.
    Ujiie H; Shibaki A; Nishie W; Shimizu H
    J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of bullous pemphigoid.
    Ujiie H; Nishie W; Shimizu H
    Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and practical diagnosis of bullous pemphigoid.
    Schmidt E; della Torre R; Borradori L
    Immunol Allergy Clin North Am; 2012 May; 32(2):217-32, v. PubMed ID: 22560135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
    Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
    J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
    Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ
    J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
    Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D
    Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BP230 autoantibodies in bullous pemphigoid.
    Shih YC; Wang B; Yuan H; Zheng J; Pan M
    J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and cutaneous autoimmune blistering diseases.
    Lessey E; Li N; Diaz L; Liu Z
    Immunol Res; 2008; 41(3):223-32. PubMed ID: 18641925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human skin basement membrane in health and in autoimmune diseases.
    Chan LS
    Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
    Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
    J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.